Clinical Trials Browser

Phase 2 × Neutropenia × eflapegrastim × Clear all

NCT01724866 2022-04-15

Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer

Phase 2 Completed

148 enrolled 45 charts

Neutropenia